# Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease

Source: https://welltoldgrants.com/grants/cdc-rfa-cd-23-0057-increasing-public-awareness-and-provider-education-about/  
Official notice: https://www.grants.gov/search-results-detail/344796

> Centers for Disease Control - OD offered grants of up to $3.0 million (at least $1.0 million) to any type of organization. It expected to make one award worth $15.0 million in total. Applications closed on May 22, 2023.

| Field | Value |
|---|---|
| Opportunity number | CDC-RFA-CD-23-0057 |
| Agency | Centers for Disease Control - OD |
| Status | Forecast |
| Deadline | May 22, 2023 |
| Award ceiling | $3.0 million |
| Award floor | $1.0 million |
| Expected awards | 1 |
| Total funding | $15.0 million |
| Cost sharing | not required |
| Assistance Listings | 93.135 |

## Who can apply

- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

## What the grant funds

Primary Immunodeficiency Diseases (PID) are a group of primarily single-gene disorders of the immune system. Primary denotes the genetic nature of the defects, differentiating them from secondary or acquired immunodeficiencies caused by malnutrition, infection, chemotherapy, or other external agents. The defining characteristics of primary immunodeficiency diseases make them candidates for a public health intervention approach. Although the clinical manifestations and underlying genetic defects are diverse, primary immunodeficiency diseases share the common feature of increased susceptibility to infection and collectively result in substantial morbidity and shortened life spans. However prompt diagnosis and treatment can be lifesaving and may result in marked improvements in the quality and length of life. The heterogeneity of primary immunodeficiency diseases and the limited understanding of the relation between genotype and phenotype also hinder intervention efforts. Additional obstacles include the difficulty of diagnosis in the absence of a high index of suspicion and the lack of awareness of health care providers and the public which impedes the timely recognition of affected person by using a combination of clinical suspicion and diagnostic testing.

## Questions people ask

### Is CDC-RFA-CD-23-0057 still open?

No. It closed on May 22, 2023. A newer notice is forecast: RFA-DP-27-030, expected deadline March 23, 2027.

### Who can apply for Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease?

Centers for Disease Control - OD accepted applications from any type of organization.

### What is the deadline for Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease?

Closed May 22, 2023. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $3.0 million each. About $15.0 million in total for one award.

### Who has won Centers for Research and Demonstration for Health Promotion and Disease Prevention grants before?

The largest recipients over five fiscal years were Emory University, University of Washington, New York University. The program made 67 awards worth $131 million in that time.